THE IMPACT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON SERUM LIPID PROFILE IN HEMODIALYSIS (HD) PATIENTS

被引：0
|
作者：
Arita, Kazuko [1 ]
Tanabe, Takehiro [1 ]
Kihara, Emi [1 ]
Maeda, Katsutoshi [1 ]
Oda, Hiroaki [1 ]
Doi, Shigehiro [2 ]
Masaki, Takao [2 ]
机构：
[1] Oda Naika Clin, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Hiroshima, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP719
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [1] Proprotein convertase subtilisin/kexin type 9 (PCSK9) and inhibitors
    Avci, Ahmet
    Demir, Kenan
    Altunkeser, Bulent Behlul
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 : 56 - 67
  • [2] THE APOPROTEIN E (APOE) POLYMORPHISM AND PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) IN HEMODIALYSIS (HD) PATIENTS
    Arita, Kazuko
    Oda, Hiroaki
    Kihara, Emi
    Maeda, Katsutoshi
    Masaki, Takao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I842 - I842
  • [3] Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors
    Leong, Derek
    Wu, Peter E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (32) : E894 - E894
  • [4] PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9): A Narrative Review
    Dua, Pamila
    Reeta, K. H.
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2020, 6 (03) : 226 - 233
  • [5] Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum
    Jabor, Antonin
    Vackova, Tereza
    Kubicek, Zdenek
    Komrskova, Jitka
    Protus, Marek
    Franekova, Janka
    CLINICA CHIMICA ACTA, 2021, 521 : 59 - 63
  • [6] Regulation of ENaC by proprotein convertase subtilisin/kexin type 9(PCSK9)
    Sharotri, Vikas
    Snyder, Peter M.
    FASEB JOURNAL, 2010, 24
  • [7] PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP"
    Silverstein, Roy L.
    CIRCULATION, 2021, 143 (01) : 62 - 64
  • [8] Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients
    Torino, Claudia
    Carbone, Federico
    Pizzini, Patrizia
    Mezzatesta, Sabrina
    D'Arrigo, Graziella
    Gori, Mercedes
    Liberale, Luca
    Moriero, Margherita
    Michelauz, Cristina
    Fre, Federica
    Isoppo, Simone
    Gavoci, Aurora
    La Rosa, Federica
    Scuricini, Alessandro
    Tirandi, Amedeo
    Ramoni, Davide
    Mallamaci, Francesca
    Tripepi, Giovanni
    Montecucco, Fabrizio
    Zoccali, Carmine
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (09)
  • [9] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy
    Joseph, Lee
    Robinson, Jennifer G.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (01) : 19 - 31
  • [10] Proprotein convertase subtilisin/kexin type 9 (PCSK9) in lipid metabolism, atherosclerosis and ischemic stroke
    Zhang, Lingling
    Song, Kangping
    Zhu, Mengting
    Shi, Jinling
    Zhang, Huijuan
    Xu, Liang
    Chen, Yingzhu
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (08) : 675 - 680
12345